The Guardian: Tobacco firm to profit from cancer genes

Published by Colin on 12th November 2001.

From the "excuse me while I be sick" department: One of the world’s biggest tobacco companies aims to make billions of pounds from the diseases caused by cigarette smoking through deals with biotech companies for the exclusive rights to market future lung cancer vaccines. (via the null device)